Balrampur Chini Mills Ltd is likely to remain in focus as the company expects its ₹3,080 crore polylactic acid (PLA) plant in Uttar Pradesh to commence commercial operations in the fourth quarter of the 2026-27 financial year. The 80,000-tonne-per-annum facility is expected to strengthen the company's presence in the bioplastics sector and emerge as a significant revenue and earnings growth driver over the coming years.
The stock has delivered strong returns to investors, rising over 50% in one year. It has gained 4% in the past three months and 26% over six months. The company's upcoming PLA facility, September-quarter earnings, interim dividend announcement and a recent upgrade by Elara Capital have brought the stock into focus.
Balrampur Chini expects its 80,000-tonne-per-annum PLA plant in Uttar Pradesh to begin commercial operations in Q4FY27. The company is investing around ₹3,080 crore in the project, which is expected to expand its presence in the bioplastics business.
Chairman and Managing Director Vivek Saraogi said in the company's latest investor presentation that construction was progressing at full pace and the project remained largely on track for its planned commissioning timeline. He indicated that execution was advancing in line with the company's plans.
As of October 15, 2026, Balrampur Chini had spent around ₹2,400 crore on the project. The investment is being financed through a combination of equity, debt and internal accruals.